Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 141160 of 20,252 grants

Active NON-SBIR/STTR RPGS
Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving equal access to care and research for all populations
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

Project Summary/Abstract Gynecologic Cancer remains an underfunded area of research with funding to lethality scores significantly lower than other cancer sites. Endometrial cancer...

$1.32M
USD
Active NON-SBIR/STTR RPGS
An Innovative Digitally-Delivered Olfactory Method for Reducing Cigarette Cravings and Supporting Smoking Cessation
NATIONAL CANCER INSTITUTE University of Houston United States 2024 – 2027

ABSTRACT Cigarette smoking is the leading cause of preventable death and disability in the United States. Smoking cessation rates have stagnated in recent years, underscoring the n...

$2.8M
USD
Active NON-SBIR/STTR RPGS
Effect of the plantar skin microenvironment on tumor metastasis and drug tolerance
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Summary Patients with advanced acral melanoma (AM) suffer worse outcomes relative to patients with cutaneous melanoma (CM), in part, because they do not respond as well to...

$4.26M
USD
Active NON-SBIR/STTR RPGS
Core A: Administration, Communication and Project Management
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

CORE A: SUMMARY/ABSTRACT This Program Project comprises four individual projects, which will: extend the WISDOM Study to evaluate the use of subtype-specific risk models and associ...

Active NON-SBIR/STTR RPGS
Project 4: CISNET Modeling of outcomes and cost for risk-based screening strategies
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

Project 4 will evaluate the benefits, harms, and costs of personalized screening using one of the CISNET models of breast cancer. We will evaluate the current approaches to persona...

Active NON-SBIR/STTR RPGS
Core B: Biostatistics and Bioinformatics
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

CORE B: SUMMARY/ABSTRACT The Biostatistics and Bioinformatics Core’s primary goal is to collaborate with the P01 Investigators and other Core resource scientists to ensure that res...

Active NON-SBIR/STTR RPGS
Core C : Population Genomic Risk Assessment
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

CORE C: SUMMARY/ABSTRACT A polygenic risk score (PRS) combines risk information from many common genetic variants associated with a disease to predict the risk of that disease. PRS...

Active NON-SBIR/STTR RPGS
Project 1: Implementing Risk-based Tools that Incorporate Tumor Biology to Optimize Screening and Prevention
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

In 2016, we initiated the first large-scale clinical trial to personalize screening based on individual risk, which varies significantly among women. The WISDOM Study is a multi-ce...

Active NON-SBIR/STTR RPGS
Core D: Patient Centered Outcomes and Risk Communication
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

CORE D: SUMMARY/ABSTRACT The ability to effect change in healthcare is as dependent on a successful implementation as it is on the intervention itself.Personalization of screening...

Completed NON-SBIR/STTR RPGS
Epidemiology of the gut-liver axis and hepatocellular carcinoma risk in a multiethnic liver cirrhosis cohort: defining the role of bacteria, metabolites, and glycoproteins
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2025

PROJECT SUMMARY Hepatocellular carcinoma (HCC) is the most common type of liver cancer in adults in which most cases develop in patients with liver cirrhosis. The incidence and mor...

$3M
USD
Active NON-SBIR/STTR RPGS
Project 2: Optimizing polygenic risk scores to inform breast cancer screening and prevention
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT 2: Summary/Abstract The ongoing WISDOM Study of risk-based versus annual breast cancer screening is one of the first-ever applications of population-wide genetic testing to...

Active NON-SBIR/STTR RPGS
Project 3: Integration of mammographic AI, clinical, and genomics information to improve breast cancer subtype-specific risk-based screening and prevention
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT 3: Summary The ongoing WISDOM risk-based breast cancer screening and prevention trial, which started in 2016, is a ground-breaking comparative effectiveness study to establ...

Completed SBIR/STTR CONTRACTS
TOPIC NUMBER: 464 SBIR PHASE I - UNIFIED DATA COMMONS SOLUTION FOR PUBLIC DOMAIN,IN-HOUSE AND THIRD-PARTY MULTIMODAL CLINICAL DATA.
NATIONAL CANCER INSTITUTE Impact Business Information Solutions In... United States 2024 – 2025

This proposal sets out to deliver a solution, EICON MULTIMODAL, that has three main objectives.Firstly, to facilitate access to multimodal clinical data in the public domain by pro...

$3.96M
USD
Completed SBIR/STTR CONTRACTS
FY24 SBIR PHASE I TOPIC NO. 459 PROJECT TITLE: AN AUTOMATED SCREENING PLATFORM FOR EARLY IDENTIFICATION OF MALNUTRITION IN CANCER PATIENTS
NATIONAL CANCER INSTITUTE Biosensics, Llc United States 2024 – 2025

This project aims to develop an automated screening platform for early identification of malnutrition in cancer patients by creating a machine-learning-based model that combines CT...

$4M
USD
Completed SBIR/STTR CONTRACTS
TOPIC NUMBER: 458 SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE IONCOBIOMIX: MICROBIOME-BASED TEST FOR PROSTATE CANCER RISK
NATIONAL CANCER INSTITUTE Oncobiomix Inc United States 2024 – 2025

Prostate cancer (PCa) remains a significant global health challenge, particularly in the United States where it is the most common non-cutaneous cancer among men. The landscape of...

$4M
USD
Active NON-SBIR/STTR RPGS
Phase Changing Ultrasound Contrast Agents for Deep Tissue Imaging of Cellular Immunotherapies
NATIONAL CANCER INSTITUTE Pennsylvania State University, The United States 2024 – 2029

PROJECT SUMMARY Adoptive cellular immunotherapies are an established therapeutic weapon in the fight against cancer. However, there is a large variability in anti-tumor responses a...

$4.9M
USD
Active NON-SBIR/STTR RPGS
Targeting EBV-associated lymphomas
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

ABSTRACT Epstein-Barr Virus (EBV) is the etiological agent of several hematopoietic malignancies including multiple types of non-Hodgkin lymphoma (NHL). These EBV-positive NHL subt...

$6.45M
USD
Completed SBIR-STTR RPGS
Optimizing non-invasive focused ultrasound for brain tumor liquid biopsy in a rat glioma model - Phase I
NATIONAL CANCER INSTITUTE Cordance Medical, Inc United States 2024 – 2025

SUMMARY The NeuroAccess system represents a pioneering approach to address the unmet critical need for effective blood-based molecular characterization in brain cancer patients. By...

$3.99M
USD
Active NON-SBIR/STTR RPGS
Built environment approaches to physical activity: Testing community-driven implementation strategies
NATIONAL CANCER INSTITUTE Chn Nebraska United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Built environment approaches make it safer and easier for people across the life span to walk, bicycle, or wheelchair roll, and mitigate barriers to physic...

$1.41M
USD
Active NON-SBIR/STTR RPGS
Tissue engineered organ-specific cancer metastasis model for cancer research
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

Understanding the biology of cancer metastases is critical to improving the treatment of cancer. A key challenge in these efforts has been the lack of cancer models that can recapi...

$5.44M
USD